Market Closed -
Australian S.E.
01:32:08 2024-05-03 EDT
|
5-day change
|
1st Jan Change
|
0.245
AUD
|
0.00%
|
|
+6.52%
|
+11.36%
|
Fiscal Period: June |
2022
|
2023
|
---|
Capitalization
1 |
15.12
|
16.33
|
Enterprise Value (EV)
1 |
-10.34
|
-5.071
|
P/E ratio
|
-1.82
x
|
-3.91
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
87.9
x
|
16.8
x
|
EV / Revenue
|
-60.1
x
|
-5.22
x
|
EV / EBITDA
|
2,551,654
x
|
1,063,293
x
|
EV / FCF
|
5,956,013
x
|
1,757,594
x
|
FCF Yield
|
0%
|
0%
|
Price to Book
|
0.6
x
|
0.75
x
|
Nbr of stocks (in thousands)
|
60,465
|
60,465
|
Reference price
2 |
0.2500
|
0.2700
|
Announcement Date
|
22-08-31
|
23-08-30
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.000156
|
0.0276
|
0.1719
|
0.9717
|
EBITDA
|
-
|
-
|
-4.052
|
-4.769
|
EBIT
1 |
-0.4486
|
-0.6121
|
-4.054
|
-4.772
|
Operating Margin
|
-287,538.46%
|
-2,219.77%
|
-2,357.84%
|
-491.1%
|
Earnings before Tax (EBT)
1 |
-0.5009
|
-1.068
|
-6.838
|
-4.174
|
Net income
1 |
-0.3522
|
-0.9152
|
-6.838
|
-4.174
|
Net margin
|
-225,778.21%
|
-3,318.93%
|
-3,977.17%
|
-429.62%
|
EPS
2 |
-0.002200
|
-0.005600
|
-0.1374
|
-0.0690
|
Free Cash Flow
|
-
|
-0.5639
|
-1.736
|
-2.885
|
FCF margin
|
-
|
-2,044.98%
|
-1,009.71%
|
-296.93%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-17
|
21-11-17
|
22-08-31
|
23-08-30
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
1.15
|
0.26
|
25.5
|
21.4
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.56
|
-1.74
|
-2.89
|
ROE (net income / shareholders' equity)
|
-
|
-168%
|
-53.8%
|
-17.7%
|
ROA (Net income/ Total Assets)
|
-
|
-8.09%
|
-14.9%
|
-12.4%
|
Assets
1 |
-
|
11.31
|
45.91
|
33.79
|
Book Value Per Share
2 |
0.0100
|
0.0500
|
0.4200
|
0.3600
|
Cash Flow per Share
2 |
0.0100
|
4.740
|
0.4200
|
0.3500
|
Capex
|
-
|
-
|
0
|
0
|
Capex / Sales
|
-
|
-
|
2.28%
|
0.23%
|
Announcement Date
|
21-11-17
|
21-11-17
|
22-08-31
|
23-08-30
|
|
1st Jan change
|
Capi.
|
---|
| +11.36% | 9.8M | | +8.96% | 105B | | -1.43% | 104B | | +4.40% | 22.94B | | -12.15% | 22.34B | | -4.36% | 19.25B | | -39.98% | 17.08B | | -10.04% | 16.96B | | +38.61% | 12.63B | | +313.59% | 8.49B |
Bio Therapeutic Drugs
|